Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2016

Oct 4, 2016

33899_dirs_2016-10-04_941c9ef6-afc0-4bc8-a739-5c83a1e8f43f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2016-10-03

Reporting Person: Chard Daniel R (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-10-03 Common Stock A 16061 Acquired 16061 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-10-03 Performance-based deferred shares $ A 210000 Acquired 2019-12-31 Common Stock (210000) Direct

Footnotes

F1: These shares will vest one-third per year on each of the first, second and third anniversaries of the grant date.

F2: Represents the maximum number of shares that may be earned under this performance-based deferred share award. The actual number of deferred shares that will vest will be determined based on the achievement of certain pre-established performance goals, including the Company's total shareholder return and the price of the Common Stock.